Human hematopoietic disease therapeutic agent containing human monocyte-macrophage colony stimulating factor as an active ingredient

摘要

A remedy for hematopoietic tissue diseases comprising human monocytic macrophage colony stimulating factor, which promotes the differentiation and multiplication of monocytic macrophages, as an active ingredient is disclosed. This remedy is to be administered before or after bone marrow transplantation for treating those who suffer from hematopoietic tissue diseases.